--- title: 'GLP-1 Comparison Chart 2026: Choose the Best Medication' date: '2026-08-16' slug: glp-1-comparison-chart-2026-choose-the-best-medication description: Explore a 2026 GLP-1 comparison chart with side‑effect, cost, and weight‑loss data. Find the medication that fits your goals and learn how to track progress with Pepio. updated: '2026-08-16' author: Dr. Benjamin Paul site: 'Pepio: GLP-1 Peptide Tracker' --- # GLP-1 Comparison Chart 2026: Choose the Best Medication ## GLP-1 Comparison Chart 2026: Why Comparing Medications Matters ## Why Comparing GLP‑1 Medications Matters in 2026 - Market changes and cost pressure - Definition: GLP‑1 use and insurer spending surged in recent years, changing access and affordability. See the PubMed Central analysis: [PMC article](https://pmc.ncbi.nlm.nih.gov/articles/PMC12403326/). - Rationale: Faster adoption and higher spending create choice complexity and cost pressure for people comparing medications. - Differences in clinical side‑effect profiles - Definition: Gastrointestinal events and other side effects vary between GLP‑1 drugs. For an overview, see the StatPearls summary: [StatPearls overview](https://www.ncbi.nlm.nih.gov/books/NBK572151/). - Rationale: Different side‑effect profiles affect how people experience a medication and which tradeoffs matter to them. - Pooled evidence shows mixed benefits and risks - Definition: Meta‑analyses and pooled reviews report varied findings on cardiovascular and gallbladder outcomes (example: BMJ meta‑analysis). - Rationale: Mixed evidence means there are tradeoffs to weigh beyond weight effects, depending on individual priorities and risks. See the BMJ meta‑analysis: [BMJ meta‑analysis](https://www.bmj.com/content/394/bmj-2026-372161/). - Real‑world differences in weight results - Definition: Observational studies report different average weight outcomes by sex and other factors; these patterns show up outside clinical trials. See the JHU public‑health analysis: [JHU study](https://publichealth.jhu.edu/2026/glp-1-weight-loss-drugs-comparably-effective-for-patients-across-age-race-and-starting-weight). - Rationale: Individual goals and expectations can shift based on real‑world patterns, so comparing medications matters for personal planning. - Common routine pain points people face - Definition: Many users struggle with missed shots, confusing side‑effect timing, and uncertain costs. - Rationale: These everyday problems make it hard to keep an accurate dose history and reliable notes for appointments. - How Pepio helps organize your routine - Definition: Pepio lets you record dose history, symptoms, injection sites, and cost notes in one place. - Rationale: Keeping a single, organized record reduces guesswork and makes it easier to review progress between appointments. Track your next shot in Pepio to keep dose history, symptoms, and weight progress organized between appointments. - What this article provides - Definition: A clear, side‑by‑side chart plus practical tracking guidance to compare medication tradeoffs. - Rationale: Use the comparison and tracking tips to keep your routine tidy and to prepare notes for clinician visits. - Disclaimer and safety reminder - Definition: Pepio is for organization and self‑tracking only. - Rationale: Pepio does not provide medical advice. Always follow instructions from your clinician, prescriber, pharmacist, or medication label. ## How to Evaluate GLP-1 Medications: Key Comparison Criteria GLP-1 medication evaluation criteria 2026 should focus on practical, trackable factors you can use day to day. Use these criteria to compare options, set expectations, and decide what to record in your routine. Recent reviews outline efficacy benchmarks and cost pressures that make operational tracking more important for users and payers (Pharmaceutical Journal; [BMJ](https://www.bmj.com/content/394/bmj-2026-372161)). - Dosing frequency & titration steps Define: how often injections occur and the planned dose increases. Why it matters: frequency affects adherence and reminder needs. Example: watch for shifting from weekly to maintenance doses and log each titration date. - Side-effect profile (nausea, constipation, appetite change) Define: common adverse effects and their timing after doses. Why it matters: symptoms influence daily comfort and whether you note food noise. Example: record onset and duration of nausea after a shot to spot patterns over weeks ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK572151/)). - Average % weight loss after 6 months Define: expected mean weight change benchmark for each medication. Why it matters: tracking percent loss helps set realistic goals and measure progress. Example: compare your percentage loss to published averages and log dates of dose changes (Pharmaceutical Journal). - Average out-of-pocket cost per month Define: typical patient expense after insurance or discounts. Why it matters: cost affects access and whether you maintain a consistent supply. Example: track monthly spend and vial supply to avoid missed doses ([BMJ](https://www.bmj.com/content/394/bmj-2026-372161)). - Injection-site rotation recommendations Define: advised patterns for changing injection locations. Why it matters: rotating sites reduces local irritation and keeps injections manageable. Example: note the site used each shot to avoid repeating the same area. - Tracking-tool compatibility (how well it works with a tracking app or calculators) Define: how easily dose schedules and vial math map into trackers and tools. Why it matters: compatible data makes logging simple and reduces errors. Example: prefer routines where you can record units, dates, and symptoms in one place. Pepio helps users turn these criteria into a practical log so routines stay organized and consistent. Teams using Pepio experience clearer dose histories and symptom timelines that support adherence. Learn more about Pepio’s approach to organizing GLP-1 routines and how it can help you track dosing, symptoms, and progress. Disclaimer: Pepio is for organization and self-tracking only. Follow instructions from your clinician, prescriber, pharmacist, or medication label. ## Pepio GLP-1 Tracker: The All‑In‑One Solution for Any GLP‑1 Medication Pepio treats tracking as the primary tool for living with any GLP‑1 treatment. A tracking-first approach helps you compare options by outcomes, not marketing. The diversity of GLP-1 effects and schedules makes organized records useful when evaluating progress and side effects ([Pharmaceutical Journal](https://pharmaceutical-journal.com/article/feature/everything-you-need-to-know-about-glp-1s-for-weight-loss-2)). The web tools are free, require no sign-up, and store data locally in your browser; Pepio for iOS adds persistent history and push notifications. - One-place record of dose, date, site, and symptoms - Automatic reminders via the Pepio iOS app eliminate reliance on memory - Symptom and food-noise logs reveal patterns for clinician visits - Pepio for iOS provides weight-plus-symptom trend charts overlaid on your dose timeline to keep progress visible - Free web calculators (dose conversion, reconstitution, titration schedules, next-dose date) complement any GLP‑1 drug A single, consistent record makes meaningful comparisons simple. Track reminders against dosing frequency to see if a weekly schedule fits your routine. Use symptom logs to link side-effect patterns to shot dates and dose changes. Compare weight-loss charts and symptom trends overlaid on your dose timeline to judge timing and momentum. When cost or vial math matters, calculators remove manual errors and save time. Pepio helps you keep those records together so you can answer the key evaluation questions. Users using Pepio report faster, less error-prone tracking compared with scattered notes or spreadsheets. Industry examples show one-tap logging and predictive charts cut manual entry time and improve visibility, which lowers friction for routine adherence ([Shotsy](https://shotsyapp.com/best-glp-1-tracker-apps/)). Pepio’s approach focuses on practical records and clear timelines, not clinical recommendations. Keep your notes clinician-ready by logging symptoms, dates, and weight changes ahead of appointments. Pepio helps you present a clean history without guessing when asked about past doses. Pepio is for organization and self-tracking only and does not provide medical advice. Learn more about Pepio’s approach to tracking GLP-1 routines and see how a tracking-first method can make your medication journey easier. ## Popular GLP‑1 Medications in 2026: Ozempic, Wegovy, Zepbound, and Mounjaro Comparing Ozempic, Wegovy, Zepbound, and Mounjaro helps you choose tracking priorities. Pepio helps you capture dose dates, symptom patterns, and injection‑site rotation so comparisons stay practical and usable. Most GLP‑1 options use a weekly injection cadence, which affects reminders and site rotation needs ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK572151/)). Trial data and cost differences shape what you should log for each drug. Ozempic often requires weekly dosing and has a relatively higher nausea rate reported in trials, around 30% ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). Trial weight‑loss signals tend to be moderate versus newer agents. Typical out‑of‑pocket cost estimates in the U.S. are about $1,000 per month without insurance ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). For tracking, log nausea timing, missed doses, and weight trends. Wegovy is also weekly and shows strong weight‑loss results in many trials. It often appears as a higher‑cost option, with out‑of‑pocket estimates near $1,350 per month in the U.S. ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). Because of its premium pricing and weight signals, users may prioritize weight, BMI, and dose‑change dates when tracking. Zepbound (tirzepatide brand) has shown some of the largest percent weight losses in trials, reported up to about 22.5% on average in pooled data ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). Trial reports also show a lower nausea incidence near 15% compared with some other agents. Those differences make symptom logging and long‑term weight curves especially useful for users monitoring expectations. Mounjaro (tirzepatide) combines GLP‑1 and additional metabolic effects. It produced notable A1C reductions in diabetes trials, about a 2.1% average drop versus 1.8% for some GLP‑1s ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). Nausea incidence is moderate, near 25%. Head‑to‑head and meta‑analyses underline meaningful differences across drugs, so tracking outcomes matters for follow‑up visits ([BMJ](https://www.bmj.com/content/394/bmj-2026-372161)). - Ozempic: weekly, strong nausea profile (~30%), moderate cost (~$1,000/month U.S.) - Wegovy: weekly, highest average weight loss in some trials, premium price (~$1,350/month U.S.) - Zepbound: weekly, strong trial weight-loss signals (reported up to ~22.5%), lower nausea incidence (~15%) - Mounjaro: differing cadence and metabolic benefits (tirzepatide), strong A1C reductions, moderate-to-high nausea incidence (~25%) Practical tracking takeaways: weekly cadence favors a single recurring reminder and clear injection‑site rotation notes. Track symptom timing, weight percentage, and any dose‑change dates to make comparisons meaningful. Pepio helps users keep those records together so progress and side effects are easier to review with clinicians. For broader context on GLP‑1 effects and side‑effect profiles, read general summaries on GLP‑1 therapies ([Healthline](https://www.healthline.com/health/weight-loss/glp1-for-weight-loss)) and comparative reviews ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK572151/), [BMJ](https://www.bmj.com/content/394/bmj-2026-372161)). Pepio is for organization and self‑tracking only and does not provide medical advice; always follow your clinician, prescriber, pharmacist, or medication label. Learn more about Pepio’s approach to tracking GLP‑1 routines and how it can help you keep dose history, symptoms, and weight progress in one place. # This compact side‑by‑side summary places Pepio first as the recommended tracking solution, followed by four common GLP‑1 options. GLP‑1 clinical profiles and side‑effect patterns vary by drug, so tracking helps you spot trends and prepare for appointments ([StatPearls](https://www.ncbi.nlm.nih.gov/books/NBK572151/)). Tracker-focused reviews show the value of a dedicated app for injection routines and symptom logs ([Shotsy](https://shotsyapp.com/best-glp-1-tracker-apps/)). Medication-level comparisons and trial figures help explain which drugs need tighter symptom or cost tracking ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). 1. Pepio (tracking solution): Aligns with all six evaluation criteria — best for reminders, injection‑site rotation, symptom logs, weight charts, and calculator-backed organization. (Recommended first row.) 2. Ozempic: Weekly dosing with notable nausea rates (~30% in trials); solid A1C effects — track symptoms and weight closely ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). 3. Wegovy: Weekly dosing with strong average weight‑loss signals and higher out‑of‑pocket cost — prioritize weight progress tracking and cost planning ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). 4. Zepbound: High trial weight‑loss percentages (~22.5%) with lower reported nausea incidence — useful for progress tracking and targeted symptom logging ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). 5. Mounjaro: Tirzepatide profile shows strong A1C reductions and moderate‑to‑high nausea (~25%); track symptoms and adherence closely ([Drugs.com](https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempic-compare-weight-loss-3570898/)). Use cases by goal: choose tighter symptom logs if you tolerate nausea poorly; prioritize weight charts if loss is your top outcome; use calculator support for compounded or unit-based dosing. Learn more about Pepio’s approach to organizing GLP‑1 routines and track your next shot in Pepio to keep dose history, symptoms, and progress in one place. Choosing a GLP-1 means weighing three trade-offs: maximum weight loss, tolerability, and cost. Comparative studies show meaningful differences in efficacy and side-effect profiles across medications ([BMJ – Comparative Effects of GLP‑1 Drugs 2026](https://www.bmj.com/content/394/bmj-2026-372161)). Cost analyses highlight the potential financial impact of these choices for patients ([PMC – Cost Impact of GLP‑1 Obesity Medications](https://pmc.ncbi.nlm.nih.gov/articles/PMC12403326/)). Match your goals to the tracking priorities you need. Practical next steps for staying organized: - Start tracking each dose and next-dose date so you stop guessing shot day. - Log symptoms and appetite changes after each shot to spot patterns before appointments. - Log monthly costs and vial usage in Pepio, and use the dose calculators to avoid conversion errors. For pricing, consult your pharmacy/insurer or reputable external resources. Pepio helps you keep dose history, reminders, injection sites, and symptom notes in one place. People using Pepio can organize doses, reminders, and symptom logs so clinician conversations are clearer. Pepio's approach focuses on simple, operational tracking tailored to GLP-1 routines. Pepio is for organization and self-tracking only. Pepio does not provide medical advice, diagnosis, treatment, dosing recommendations, or protocol recommendations. Always follow the instructions from your clinician, prescriber, pharmacist, medication label, or care team.